11:09 AM EDT, 04/02/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were treading water late Wednesday morning, edging 0.01% higher to 1,393.26 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by accommodations booking company trivago (TRVG) and furniture maker Natuzzi (NTZ), which advanced 6% and 3% respectively. They were followed by biopharmaceutical companies DBV Technologies ( DBVT ) and Grifols ( GRFS ) , which increased 4.5% and 3.3% respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis ( CLLS ) and electronics conglomerate Royal Philips (PHG), which lost 4.6% and 1.9% respectively. They were followed by petroleum refiner Equinor ( EQNR ) and telecommunications company Ericsson (ERIC), which dropped 0.9% and 0.7% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics ( SLN ) and biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which climbed 18% and 16% respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Mereo BioPharma Group ( MREO ) , which rose 6.7% and 3.9% respectively.

The decliners from the UK and Ireland were led by mining company BHP Group ( BHP ) and biopharmaceutical company Amarin ( AMRN ) , which fell 2.1% and 1.4% respectively. They were followed by biopharmaceutical company Akari Therapeutics ( AKTX ) and telecommunications operator Vodafone Group ( VOD ) , which were down 1.7% and 1.4% respectively.